Your browser doesn't support javascript.
loading
Conditional immortalization of human atrial myocytes for the generation of in vitro models of atrial fibrillation.
Harlaar, Niels; Dekker, Sven O; Zhang, Juan; Snabel, Rebecca R; Veldkamp, Marieke W; Verkerk, Arie O; Fabres, Carla Cofiño; Schwach, Verena; Lerink, Lente J S; Rivaud, Mathilde R; Mulder, Aat A; Corver, Willem E; Goumans, Marie José T H; Dobrev, Dobromir; Klautz, Robert J M; Schalij, Martin J; Veenstra, Gert Jan C; Passier, Robert; van Brakel, Thomas J; Pijnappels, Daniël A; de Vries, Antoine A F.
Afiliação
  • Harlaar N; Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Dekker SO; Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • Zhang J; Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Snabel RR; Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Veldkamp MW; Department of Molecular Developmental Biology, Radboud University, Nijmegen, the Netherlands.
  • Verkerk AO; Department of Clinical and Experimental Cardiology, Amsterdam UMC, Amsterdam, the Netherlands.
  • Fabres CC; Department of Clinical and Experimental Cardiology, Amsterdam UMC, Amsterdam, the Netherlands.
  • Schwach V; Department of Medical Biology, Amsterdam UMC, Amsterdam, the Netherlands.
  • Lerink LJS; Applied Stem Cell Technologies, University of Twente, Enschede, the Netherlands.
  • Rivaud MR; Applied Stem Cell Technologies, University of Twente, Enschede, the Netherlands.
  • Mulder AA; Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Corver WE; Department of Clinical and Experimental Cardiology, Amsterdam UMC, Amsterdam, the Netherlands.
  • Goumans MJTH; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.
  • Dobrev D; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
  • Klautz RJM; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.
  • Schalij MJ; Institute of Pharmacology, University Duisburg-Essen, Essen, Germany.
  • Veenstra GJC; Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • Passier R; Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
  • van Brakel TJ; Department of Molecular Developmental Biology, Radboud University, Nijmegen, the Netherlands.
  • Pijnappels DA; Applied Stem Cell Technologies, University of Twente, Enschede, the Netherlands.
  • de Vries AAF; Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, the Netherlands.
Nat Biomed Eng ; 6(4): 389-402, 2022 04.
Article em En | MEDLINE | ID: mdl-34992271
ABSTRACT
The lack of a scalable and robust source of well-differentiated human atrial myocytes constrains the development of in vitro models of atrial fibrillation (AF). Here we show that fully functional atrial myocytes can be generated and expanded one-quadrillion-fold via a conditional cell-immortalization method relying on lentiviral vectors and the doxycycline-controlled expression of a recombinant viral oncogene in human foetal atrial myocytes, and that the immortalized cells can be used to generate in vitro models of AF. The method generated 15 monoclonal cell lines with molecular, cellular and electrophysiological properties resembling those of primary atrial myocytes. Multicellular in vitro models of AF generated using the immortalized atrial myocytes displayed fibrillatory activity (with activation frequencies of 6-8 Hz, consistent with the clinical manifestation of AF), which could be terminated by the administration of clinically approved antiarrhythmic drugs. The conditional cell-immortalization method could be used to generate functional cell lines from other human parenchymal cells, for the development of in vitro models of human disease.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article